The FDA approved Eylea HD for the treatment of macular edema following retinal vein occlusion, according to a press ...

Politico reports that Health Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary, MD, MPH, are at odds on how ...

The FDA has approved Eylea HD (aflibercept) 8 mg to treat patients with macular edema following retinal vein occlusion (RVO) with dosing of up to every 8 weeks after an initial monthly dosing period.

Nvidia’s outlook also boosted other AI stocks as investors put aside the their fears about lofty valuations. Data analytics ...

First and only FDA-approved treatment for RVO indicated for up to every 8-week dosing after an initial monthly dosing period Monthly dosing ...

Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the third ...

Third Quarter 2025 Financial Highlights - Cash Position: Cash and cash equivalents were $81.3 million as of September 30, 2025, compared to $90.4 million as of June 30, 2025. - Revenue: ...

A South Korean research team has succeeded in recreating an incurable eye disease that causes blindness using 3D bioprinting ...

Patients who experience retinal vascular occlusions may not have higher risk for dementia, but may benefit from enhanced screening anyway. The connection between a retinal vascular occlusions and ...

ABSTRACT: Aim: This study aims to present a rare case of branch retinal vein occlusion (BRVO) that developed after cataract surgery and to evaluate possible preoperative and intraoperative risk ...

ABSTRACT: Aim: This study aims to present a rare case of branch retinal vein occlusion (BRVO) that developed after cataract surgery and to evaluate possible preoperative and intraoperative risk ...